This ASX All Ordinaries share shrugged off the red to reach a new 52-week high today

We take a look at an All Ordinaries share that outperformed the index, and itself, today.

| More on:
Four people on the beach leap high into the air.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX All Ordinaries healthcare share Ebos outperformed the index today 
  • The company's share price is trading at an all-time high 
  • The All Ordinaries Index slipped 0.89% in today's trade 

The All Ordinaries Index (ASX: XAO) fell 0.89% today. But this share bucked the trend to leap higher.

The Ebos Group Ltd (ASX: EBO) share price climbed 1.76% today to close at a yearly high $41.57.

Let's take a look at the Ebos Group in more detail.

What does this ASX All Ordinaries share do?

Ebos is a marketer, wholesaler and distributor of healthcare, medical, animal care and pharmaceutical products in Australia, New Zealand and South East Asia.

Healthcare represents 87% of the company's business, with the other 13% of the company devoted to animal care.

Ebos shares are currently trading at an all-time high.

In a recent investor presentation, Ebos highlighted it makes over 12 million deliveries a year to healthcare providers and end markets.

Ebos reported $10.7 billion in revenue in the 2022 financial year. While underlying net profit after tax (NPAT) lifted 21.3% to $228.2 million.

The company delivered a final dividend of NZ 49 cents per share in FY22. Overall in FY22, Ebos delivered 96 cents per share of dividends to investors, up 8.5% on the previous year.

Ebos has acquired 20 companies since 2014. In May, Ebos acquired LifeHealthcare, one of the largest medical device distributors in Australia, New Zealand and South East Asia. Ebos sees this acquisition as an expansion opportunity. Commenting on this acquisition in November, Ebos said: "The LifeHealthcare acquisition established our presence in Southeast Asia and opens other potential opportunities in the region."

Ebos share price snapshot

The Ebos share price has climbed 4.45% in the last year. Meanwhile, Ebos shares are up 8.54% year to date. The All Ords share has a market capitalisation of $7.78 billion.

For perspective, the ASX All Ordinaries Index has shed 8.2% in the past year and 7.48% in the year to date.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man looking happy and excited as he looks at his mobile phone.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on big news

This stock is getting a lot of attention from investors on Wednesday. But why?

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Healthcare Shares

How much further upside is there for Mesoblast shares after soaring 23% in a month?

Could FDA approval send this healthcare stock towards further gains?

Read more »

woman in lab coat conducting testing representing biotech
Healthcare Shares

Is this soaring ASX 200 healthcare share just getting started?

If its lead therapy gets US approval, the stock can continue to climb.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Own CSL shares? Here are the key dates for 2026

It's been a bad year for CSL shares. What's ahead in 2026?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Healthcare Shares

Is Sigma Healthcare share a healthy buy, after hitting new lows?

The Chemist Warehouse merger and ageing population might boost this stock's appeal.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Telix shares fall despite 'significant milestone'

Let's see what the biotech has announced on Monday.

Read more »